Related Experiment Video
Updated: Nov 6, 2025

Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model
Published on: August 16, 2020
EARN: an ensemble machine learning algorithm to predict driver genes in metastatic breast cancer
Leila Mirsadeghi1, Reza Haji Hosseini2, Ali Mohammad Banaei-Moghaddam3
1Department of Biology, Faculty of Science, Payame Noor University, Tehran, Iran.
This study identifies key driver genes for metastatic breast cancer (MBCA) using an ensemble classifier (EARN). The findings aid in developing targeted gene panels for precision oncology, improving diagnosis and treatment strategies.
Area of Science:
- Genomics
- Computational Biology
- Oncology
Background:
- Limited understanding of drivers influencing cancer aggression in complex diseases like breast cancer.
- Need for better prognostic and diagnostic markers for primary and metastatic breast cancer.
Purpose of the Study:
- To identify plausible driver genes for metastatic breast cancer (MBCA) using somatic mutation data.
- To develop an ensemble classifier (EARN) for evaluating driver genes.
- To propose a novel gene set panel for MBCA prognosis and diagnosis.
Main Methods:
- Analysis of 450 metastatic breast tumor samples from cBio Cancer Genomics Portal.
- Feature extraction using four software tools.
- Development and application of an ensemble classifier (EARN) combining Artificial Neural Network, Random Forest, and non-linear Support Vector Machine.
- Gene set enrichment analysis and pathway enrichment analysis (PEA) using ReactomeFIVIz.
Main Results:
- Identification of predicted driver and passenger genes.
- Proposed a novel gene set panel for MBCA including HDAC3, ABAT, GRIN1, PLCB1, KPNA2, NCOR1, TBL1XR1, SIRT4, KRAS, CACNA1E, PRKCG, GPS2, SIN3A, ACTB, KDM6B, and PRMT1.
- Achieved high ROC-AUC values (99.24% for MBCA, 99.79% for BRCA) using EARN, outperforming individual classifiers.
Conclusions:
- The integrative approach assists precision oncologists in designing targeted gene panels.
- Eliminates the need for whole-genome/exome sequencing for certain applications.
- Provides a foundation for improved diagnostic and therapeutic strategies in breast cancer.
More Related Videos
07:41A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis
Published on: March 8, 2022
04:09Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
Published on: October 10, 2018